Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

INTRODUCTION: Multiple myeloma (MM) is a relatively common and incurable hematological malignancy. Currently, there is no single standard therapy, with choice of treatment dependent on individual patient factors. Lenalidomide is an immunomodulatory drug with potent antitumor, antiangiogenic, immunom...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Richardson, Paul, Mitsiades, Constantine, Laubach, Jacob, Schlossman, Robert, Ghobrial, Irene, Hideshima, Teru, Munshi, Nikhil, Anderson, Kenneth
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2010
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2899783/
https://ncbi.nlm.nih.gov/pubmed/20694078
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg